Heteroaryl compounds as modulators of AKT activity

Abstract

Provided herein are compounds of Formula (I): ， or a stereoisomer, a mixture of stereoisomers, a tautomer, or a pharmaceutically acceptable salt thereof, which may be used as modulators of AKT signaling. Also provided are pharmaceutical compositions comprising the compounds and methods of treating a cell proliferative disease (e.g., cancer) using the compounds.